In determining the impact of sacubitril on HF after MI, our meta-analysis revealed that the drug was successful in enhancing the outcomes of HF, NT-proBNP, and MACE, yielding significant results when compared to the control group. The gene discussed is NPPB; the disease is hydrops fetalis.